INQ000408453 - Press release from the Medicines and Healthcare products Regulatory Agency titled MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, dated 07/04/2021.

Rydych chi'n defnyddio porwr gwe gyda JavaScript wedi'i analluogi. Mae’n bosibl na fydd rhai o nodweddion y wefan hon yn gweithredu fel y bwriadwyd.

Press release from the Medicines and Healthcare products Regulatory Agency titled MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, dated 07/04/2021.

Modiwl 4 a godwyd:

• Tudalennau 1, 4 ar 22 Ionawr 2025

Gwneud lawrlwytho'r ddogfen hon

Saesneg (PDF)